Download - ISPOR 14th annual European congress financial disclosure information for research presetnations

ISPOR 14TH ANNUAL EUROPEAN CONGRESS FINANCIAL DISCLOSURE INFORMATION FOR RESEARCH PRESETNATIONS

The International Society for Pharmacoeconomics and Outcomes Research asked all abstract contributors to disclose financial support for their research.The following financial support was declared:

ReferenceCode Financial Support


AD1 NoneAD2 Janssen-Cilag SpA, Milano, ItalyAD3 NoneAD4 Mediguard, Rockville, MD, USA SACN1 Bristol-Myers Squibb, Wallingford, CT, USACN2 University of Twente, Enschede, The Netherlands; Sawtooth Software,

Sequim, WA, USACN3 Pfizer Global Health Partnership, New York, NY, USA; EORTC Charitable

Trust, Bruxelles, Belgium; King Baudouin Foundation, Bruxelles, Belgium;Belgian Cancer Foundation, Bruxelles, Belgium

CN4 Briston-Myers Squibb, Princeton, NJ, USADA1 NoneDA2 ZonMw, Den Haag, The NetherlandsDA3 NoneDA4 NoneHG1 NoneHG2 NoneHG3 Health Research Board, Dublin, IrelandHG4 NoneHT1 NoneHT2 NoneHT3 Quintiles, Hoofddorp, The NetherlandsHT4 NoneMA1 Allergan, Irvine, CA, USAMA2 Janssen, High Wycombe, UKMA3 NoneMA4 NoneMO1 National Institute for Health Research, London, UKMO2 BMS, Brussels, BelgiumMO3 National Institute for Health Research, London, UKMO4 ZONMw, The Hague, The NetherlandsMT1 BMS, Plainsboro, NJ, USAMT2 NoneMT3 HTA Consulting, Cracow, PolandMT4 NoneNI1 NETSCC, Southampton, UKNI2 Medtronic, Tolochenaz, SwitzerlandNI3 NoneNI4 Eli Lilly, Indianapolis, IN, USAPCN1 Pfizer Oncology, New York, NY, USAPCN2 Bristol-Myers Squibb Canada, Montreal, QC, CanadaPCN3 NonePCN4 Eisai Inc., Woodcliff Lake, NJ, USAPCN5 Eisai Inc., Woodcliff Lake, NJ, USAPCN6 Eisai Inc., Woodcliff Lake, NJ, USAPCN7 Amgen, Brussels, BelgiumPCN8 NonePCN9 Amgen, Inc., Thousand Oaks, CA, USAPCN10 Amgen, Inc., Thousand Oaks, CA, USAPCN11 NonePCN12 BMS Spain, Madrid, SpainPCN13 iOMEDICO AG, Freiburg, GermanyPCN14 NonePCN15 NonePCN16 Novartis Pharmaceuticals Corporation, Florham Park, NJ, USAPCN17 Institute of Health Carlos III and Spanish Ministry of Health, Madrid, SpainPCN18 NonePCN19 Sanofi Pasteur MSD, Maidenhead, UKPCN20 Bristol-Myers Squibb , Lawrenceville, NJ, USAPCN21 Bristol-Myers Squibb, Lawrenceville, NJ, USAPCN22 NonePCN23 Janssen-Cilag Limited, High Wycombe, UKPCN24 NonePCN25 Fondo de Investigacion Sanitaria, Madrid, SpainPCN26 Takeda Global Research & Development Centre (Europe) Ltd., London, UKPCN27 NonePCN28 Evidencias, Campinas, BrazilPCN29 Evidencias, Campinas, BrazilPCN30 Abbott Laboratories, Abbott Park, IL, USAPCN31 Novartis Biociencias SA, Sao Paulo, BrazilPCN32 Croatian Society for Pharmacoeconomics and Health Economics, Zagreb,

CroatiaPCN33 Amgen, Zug, SwitzerlandPCN34 Amgen, Zug, Switzerland

PCN35 Evidencias, Campinas, BrazilPCN36 Canadian Institute for Health Research, Ottawa, ON, CanadaPCN37 ROCHE SAS, Neuilly Sur Seine, FrancePCN38 Genesis Pharma, Athens, GreecePCN39 Abbott Laboratories, Abbott Park, IL, USAPCN40 Amgen, Inc., Thousand Oaks, CA, USAPCN41 GlaxoSmithKline, Marly le Roi, FrancePCN42 NonePCN43 MSD, Moscow, RussiaPCN44 Sanofi Pasteur MSD, Maidenhead, UKPCN45 BMS, Rueil Malmaison, FrancePCN46 NonePCN47 NonePCN48 Novartis Biociencias SA, Sao Paulo, BrazilPCN49 NonePCN50 Pfizer Oncology, New York, NY, USAPCN51 Abbott, Abbott Park, IL, USAPCN52 Bristol-Myers Squibb, Brussels, BelgiumPCN53 Sanofi Pasteur MSD, Lyon, FrancePCN54 Janssen, Issy-les-Moulineaux, FrancePCN55 Genomic Health, Geneva, SwitzerlandPCN56 Genentech Inc., South San Francisco, CA, USAPCN57 NonePCN58 Janssen Cilag Farmaceutica, Sao Paulo, BrazilPCN59 NonePCN60 GlaxoSmithKline, Moscow, RussiaPCN61 AstraZeneca, Macclesfield, UKPCN62 GlaxoSmithKline Biologicals, Wavre, BelgiumPCN63 Pfizer Portugal, Porto Salvo, PortugalPCN64 NETSCC, London, UKPCN65 Novartis Pharmaceuticals Corporation, Florham Park, NJ, USAPCN66 Roche, Sao Paulo, BrazilPCN67 Roche, Sao Paulo, BrazilPCN68 Institut Paoli-Calmettes, Marseille, FrancePCN69 Roche Farma S.A., Madrid, SpainPCN70 Merck KGaA-Merck Serono, Darmstadt, GermanyPCN71 Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USAPCN72 GlaxoSmithKline, Madrid, SpainPCN73 Novartis Pharmaceuticals, East Hanover, NJ, USAPCN74 NonePCN75 Merck & Co., Inc., Whitehouse Station, NJ, USAPCN76 CONnective Tissue Cancers NETwork to integrate European Experience in

Adult and Children -project no. LSHC-CT-2005-018806, BRUXELLES,Belgium; Clara, Lyon, France

PCN77 Amgen, Neuilly-sur-Seine, FrancePCN78 ZonMw, Den Haag, The NetherlandsPCN79 Roche, Paris, FrancePCN80 NonePCN81 NonePCN82 Roche Hellas, Athens, GreecePCN83 NonePCN84 NonePCN85 NonePCN86 Roche Polska Sp. z o.o., Warsaw, PolandPCN87 MerckSerono UK, Feltham, UKPCN88 Amgen, Neuilly-sur-Seine, FrancePCN89 Merck & Co., Inc., Whitehouse Station, NJ, USAPCN90 NonePCN91 NonePCN92 Celgene, Lisboa, PortugalPCN93 The Netherlands Organization for Health Research and Development, Den

Hague, The NetherlandsPCN94 NonePCN95 Merck & Co, Whitehouse Station, NJ, USAPCN96 NonePCN97 NonePCN98 Robert Koch Institute, Berlin, GermanyPCN99 Bristol-Myers Squibb, Paco de Arcos, PortugalPCN100 Ferring International, Saint-Prex, SwitzerlandPCN101 Janssen-Cilag, High Wycombe, UKPCN102 Astellas Pharma Europe, Staines, UKPCN103 Roche Products Limited, Welwyn Garden City, UKPCN104 Roche, Bucharest, RomaniaPCN105 Amgen-Hellas, Athens, Greece

A511V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 5 1 1 - A 5 2 0

Copyright © 2011, International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.

PCN106 Dutch Health Care Insurance Board (CVZ), Diemen, The NetherlandsPCN107 NonePCN108 Pfizer China, Beijing, ChinaPCN109 NonePCN110 Astra Zeneka, Athens, GreecePCN111 NonePCN112 Ontario Cancer Research Network, Toronto, ON, CanadaPCN113 Janssen Korea, Seoul, South KoreaPCN114 Baxter Healthcare SA, Zurich, SwitzerlandPCN115 Amgen (Europe) GmbH, Zug, SwitzerlandPCN116 Amgen (Europe) GmbH, Zug, SwitzerlandPCN117 Amgen (Europe) GmbH, Zug, SwitzerlandPCN118 NonePCN119 F. Hoffmann-La Roche AG, Basel, SwitzerlandPCN120 GlaxoSmithKline, Collegeville, PA, USAPCN121 Pfizer, New York, NY, USAPCN122 Universiti Teknologi MARA (UiTM), Pulau Pinang, MalaysiaPCN123 Sanofi Pasteur MSD, Lyon, FrancePCN124 Medical Research Council, London, UKPCN125 Novartis Pharmaceuticals Corporation, Florham Park, NJ, USAPCN126 Pfizer Korea, Seoul, South KoreaPCN127 National University of Singapore, Singapore, SingaporePCN128 Sanofi-aventis, Bridgewater, NJ, USAPCN129 NonePCN130 Astellas Pharma, Leiderdorp, The NetherlandsPCN131 Instituto de Salud Carlos III, Madrid, Spain; AGAUR, Barcelona, SpainPCN132 NonePCN133 Kyung Hee University, Seoul, South KoreaPCN134 Boehringer Ingelheim GmbH, Ingelheim, GermanyPCN135 GlaxoSmithKline, Marly le Roi, FrancePCN136 Universiti Teknologi MARA (UiTM), Pulau Pinang, MalaysiaPCN137 GlaxoSmithKline, Espoo, Finland; The Finnish Cancer Organisations, Helsinki,

FinlandPCN138 Roche Farma S.A., Madrid, SpainPCN139 NonePCN140 NonePCN141 Celgene Corporation, Summit, NJ, USAPCN142 NonePCN143 NonePCN144 NonePCN145 National Medical Research Council, Singapore, SingaporePCN146 NonePCN147 NonePCN148 Bristol-Myers Squibb, Uxbridge, UKPCN149 Pfizer, Sandwich, UKPCN150 Genentech Inc., S San Francisco, CA, USAPCN151 Bayer Schering Pharma AG, Berlin, GermanyPCN152 National Cancer Institute, NIH, Bethesda, MD, USAPCN153 NonePCN154 NonePCN155 Pfizer Ltd., Tadworth, UKPCN156 Eli Lilly, Indianapolis, IN, USAPCN157 Celgene Corporation, Cambridge, MA, USAPCN158 National Human Genome Research Institute, NIH, Bethesda, MD, USAPCN159 NonePCN160 Health Research Board (HRB), Dublin, IrelandPCN161 Bristol-Myers Squibb, Princeton, NJ, USAPCN163 NonePCN164 NonePCN165 Sanofi Pasteur MSD, Lyon, FrancePCN166 Pfizer Pharmaceuticals Korea Limited, Seoul, South KoreaPCN167 Pfizer, Inc, Seoul, South KoreaPCN168 NonePCN169 Groupement pour l’Elaboration et la Realisation de Statistique, Boulogne,

FrancePCN170 NonePCN171 NonePCN173 NonePCN174 NonePCN175 Institut national d’excellence en sante et en services sociaux (INESSS),

Quebec, QC, CanadaPCN176 NonePCN177 NonePCN178 NonePCN179 NonePCN180 NonePCN181 NonePCN182 National Cancer Center, Tokyo, JapanPCN183 ZonMw, Den Haag, The NetherlandsPCN184 NonePCN185 Pfizer Inc, New York, NY, USA

PCN186 NonePCN187 Amgen, Inc., Thousand Oaks, CA, USAPCN188 Merck Serono, Darmstadt, Germany; Amgen, Munich, GermanyPCN189 Bristol-Myers Squibb Ltd., Uxbridge, UKPCN190 Institut national d’excellence en sante et en services sociaux (INESSS),

Quebec, QC, Canada; Fonds de la recherche en sante du Quebec, Quebec,QC, Canada

PCN191 Roche Korea, Seoul, South KoreaPCN192 NonePCN193 National Institute for Health Research, London, UKPCN194 NonePCN195 NonePCN196 NonePCN197 ZONMW, Den Haag, The NetherlandsPCN198 NonePCN199 AstraZeneca, Wilmington, DE, USAPCN200 Pfizer Oncology, New York, NY, USAPCN201 Qatar University, Doha, QatarPCV1 Bristol-Myers Squibb S.r.l., Rome, ItalyPCV2 NonePCV3 NonePCV4 Sanofi, Warsaw, PolandPCV5 NonePCV6 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

Inc., Montgomery, AL, USAPCV7 Pfizer, Madrid, SpainPCV8 Otsuka America Pharmaceutical, Inc., Rockville, MD, USAPCV9 Daiichi Sankyo, Inc., Tokyo, Japan; Eli Lilly and Company, Indianapolis, IN,

USAPCV10 Abbott Labs, Abbott Park, IL, USAPCV11 Daiichi Sankyo, Inc., Tokyo, Japan; Eli Lilly and Company, Indianapolis, IN,

USAPCV12 Pfizer Ltd., Surrey, UKPCV13 AstraZeneca, Wilmington, DE, USAPCV14 sanofi, Sydney, AustraliaPCV15 NonePCV16 NonePCV17 Actelion, Moscow, RussiaPCV18 The Medicines Company, Abingdon, UKPCV19 NonePCV20 NonePCV21 NonePCV22 NonePCV23 AstraZeneca UK Ltd., Luton, UKPCV24 NonePCV25 MSD Ltd., Hertford Road, Hoddesdon, Hertfordshire, UKPCV26 NonePCV27 NonePCV28 NonePCV29 Amgen Inc., Thousand Oaks, CA, USAPCV30 Amgen Inc., Thousand Oaks, CA, USAPCV31 NonePCV32 AstraZenca, Wilmington, DE, USAPCV34 Daiichi Sankyo, Inc., Parsippany, NJ, USAPCV35 NonePCV36 GlaxoSmithKline, London, UKPCV37 Novonordisk, Malmö, SwedenPCV38 AstraZeneca, Wilmington, DE, USAPCV39 Pfizer, Berlin, Germany; Bristol-Myers Squibb, Muenchen, GermanyPCV40 MSD, Madrid, SpainPCV41 GE Healthcare, Chalfont St Giles, UKPCV42 Daiichi-Sankyo Europe GmbH, Munich, GermanyPCV43 NonePCV44 Roche Diagnostics, Vienna, AustriaPCV45 Astrazeneca, Madrid, SpainPCV46 NonePCV47 NonePCV48 NonePCV49 NonePCV50 Sanofi-Aventis, Montreal, QC, CanadaPCV51 AstraZeneca, Zug, SwitzerlandPCV52 Sanofi-aventis, Guildford, UKPCV53 Medtronic, Madrid, SpainPCV54 NonePCV55 NonePCV56 SANOFI-AVENTIS, Athens, GreecePCV57 Böhringer Ingelheim, Vienna, AustriaPCV58 Institute for Health Economics and Policy, Tokyo, JapanPCV59 Merck & Co, Inc, Whitehouse Station, NJ, USAPCV60 Boehringer ingelheim Pty Limited, North Ryde, AustraliaPCV61 Boehringer Ingelheim, Barcelona, Spain



A512 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 5 1 1 - A 5 2 0

PCV62 Pfizer, Madrid, SpainPCV63 Boehringer Ingelheim, Madrid, SpainPCV64 NonePCV65 NonePCV66 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

Inc., Montgomery, AL, USAPCV67 National Insitute for Food and Nutrition Science, Budapest, HungaryPCV68 Medco Health Solutions, Franklin Lakes, NJ, USAPCV69 Sanofi-Aventis, Gouda, The NetherlandsPCV70 AstraZeneca GmbH, Wedel, GermanyPCV71 NonePCV72 AstraZeneca Pharma Poland, Warsaw, PolandPCV73 NIHR Health Technology Assessment Programme, Southampton, UKPCV74 National Institute of Health Research, London, UKPCV75 NonePCV76 SANOFI-AVENTIS, Athens, GreecePCV77 Boehringer Ingelheim Hellas, Athens, GreecePCV78 SANOFI-AVENTIS, Athens, GreecePCV79 Astra Zeneka, Athens, GreecePCV80 NonePCV81 AstraZeneca Canada, Toronto, ON, CanadaPCV82 Novartis Pharma AG, Basel, SwitzerlandPCV83 AstraZeneca, Athens, GreecePCV84 Takeda, Vienna, AustriaPCV85 NonePCV86 AstraZeneca, Wilmington, DE, USAPCV87 Astra Zeneca, Zoetermeer, The NetherlandsPCV88 AstraZeneca, Wilmington, DE, USAPCV89 Astrazeneca, Madrid, SpainPCV90 Transition Patient Services, Shrewsbury, NJ, USAPCV91 Instituto de Salud Carlos III, Madrid, SpainPCV92 Grupo Menarini, Barcelona, SpainPCV93 NonePCV94 sanofi australia pty Ltd., Sydney, AustraliaPCV95 SINOPEC, Port Harcourt, NigeriaPCV96 NonePCV97 New Zealand Ministry of Health, Wellington, New ZealandPCV98 NonePCV99 NonePCV100 AstraZeneca UK, Luton, UKPCV101 IRSC, Montreal, QC, CanadaPCV102 Novartis, Emmaus, PA, USAPCV103 Ministry of Higher Education, Malaysia, Malaysia, MalaysiaPCV104 Daiichi Sankyo Europe GmbH, Munich, GermanyPCV105 Pfizer, New York, NY, USAPCV106 NonePCV107 NonePCV108 sanofi, Sydney, AustraliaPCV109 Silpakorn University Research and Development Institute, Nakhon Pathom,

ThailandPCV110 Boehringer Ingelheim, Ingelheim, GermanyPCV111 Merck, Sharp & Dohme, Whitehouse Station, NJ, USAPCV112 Daiichi Sankyo Europe GmbH, Munich, GermanyPCV113 Daiichi Sankyo Europe GmbH, Munich, GermanyPCV114 NIHR Heallth Technology Assessment Programme, Southampton, UKPCV115 NonePCV116 Kantar Health, Princeton, NJ, USAPCV117 Daiichi Sankyo Europe, Munich, GermanyPCV118 Shire , Boulogne Billancourt, FrancePCV119 Novartis Farmaceutica, S.A., Barcelona, SpainPCV120 Medtronic, Madrid, SpainPCV121 Novartis Pharma AG, Basel, SwitzerlandPCV122 Servier, Lyon, FrancePCV123 NonePCV124 The Social Insurance Institution, Helsinki, FinlandPCV125 Sanofi-Aventis, Guildford, UKPCV126 HTA Consulting, Krakow, Poland; Sequence HC Partners, Warszawa, PolandPCV127 Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USAPCV128 Bayer, Newbury, UKPCV129 Servier Poland, Warsaw, PolandPCV131 NonePCV132 Boehringer Ingelheim, Ingelheim am Rhein, GermanyPCV133 NonePCV134 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

Inc., Montgomery, AL, USAPCV135 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

Inc., Montgomery, AL, USAPCV136 Eli Lilly and Company, Indianapolis, IN, USA; Kowa Pharmaceuticals America,

Inc., Montgomery, AL, USAPCV137 NonePCV138 None

PCV139 Boehringer Ingelheim, Sao Paulo, BrazilPCV140 Ministry of Health & Welfare, Seoul, South KoreaPCV141 Eli-Lilly and Co Greece, Athens, GreecePCV142 NonePCV144 Bayer Schering Pharma AG, Wuppertal, GermanyPCV145 NonePCV146 NonePCV147 NonePCV148 NonePC1 Lundbeck SAS, Issy-les-Moulineaux, FrancePC2 NonePC3 Health Research Board, Dublin, Ireland; Irish Cancer Society, Dublin, IrelandPC4 Instituto de Salud Carlos III, ISCIII GR09/0026, Madrid, SpainPDB1 NonePDB2 NonePDB3 sanofi-aventis, Montreal, QC, CanadaPDB4 Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USAPDB5 Sanofi-Aventis, Berlin, GermanyPDB6 Eli Lilly and Company, Indianapolis, IN, USAPDB7 Sanofi-Aventis, Laval, QC, CanadaPDB8 Lilly and Co. Ltd., Indianapolis, IN, USA; Amylin Pharmaceuticals Inc, San

Diego, CA, USAPDB9 Bristol-Meyers Squibb, Princeton, NJ, USAPDB10 Amylin Pharmaceuticals, Inc., San Diego, CA, USA; Eli Lilly and Company,

Indianapolis, IN, USAPDB11 Amylin Pharmaceuticals, Inc., San Diego, CA, USAPDB12 sanofi-aventis, Bridgewater, NJ, USAPDB13 sanofi-aventis, Laval, QC, CanadaPDB14 NovoNordisk, Vandtårnsvej, Søborg, DenmarkPDB15 NA, Serbia and MontenegroPDB16 NOVARTIS, Rueil-Malmaison, FrancePDB17 NonePDB18 PFSA, Boulogne, FrancePDB19 Novo Nordisk Pharma Sp. z o.o., Warsaw, PolandPDB20 NonePDB21 Eli Lilly and Company, Indianapolis, IN, USAPDB22 Eli Lilly and Company, Indianapolis, IN, USAPDB23 NonePDB24 Novo Nordisk Farmaceutici Spa, Rome, ItalyPDB25 sanofi-aventis U.S., Inc, A SANOFI Company, Bridgewater, NJ, USAPDB26 Eli Lilly and Company, London, UKPDB27 Eli Lilly and Company, London, UKPDB28 Eli Lilly and Company, Indianapolis, IN, USAPDB29 Novo Nordisk, Sofia, BulgariaPDB30 NonePDB31 Croatian Society for Pharmacoeconomics and Health Economics, Zagreb,

CroatiaPDB32 Novo Nordisk Sp. z o.o., Warsaw, PolandPDB33 NonePDB34 NonePDB35 Lilly UK, Surrry, UKPDB36 Boehringer Ingelheim Ltd., Berkshire, Bracknell, UKPDB37 IPSEN, PARIS, FrancePDB38 Novartis, Vienna, AustriaPDB39 Bristol-Myers Squibb Ltd., Uxbridge, UKPDB40 Novo Nordisk Pharma Sp. z o.o., Warsaw, PolandPDB41 Janssen-Cilag S.A., Madrid, SpainPDB42 Merck Serono, Athens, GreecePDB43 Janssen-Cilag S.A., Madrid, SpainPDB44 Takeda, London, UKPDB45 Novo Nordisk, Lda., Lisbon, PortugalPDB46 NonePDB47 AstraZeneca, Molndal, SwedenPDB48 Novo Nordisk, Copenhagen, DenmarkPDB49 Eli Lilly and Company, Indianapolis, IN, USAPDB50 Novartis, Florham Park, NJ, USAPDB51 Novo Nordisk, Princeton, NJ, USAPDB52 NonePDB53 NonePDB54 Novartis, Basel, SD, SwitzerlandPDB55 NonePDB56 AMGEN, Barcelona, SpainPDB57 NonePDB58 Merck and Company, Inc., Whitehouse Station, NJ, USAPDB59 Novo Nordisk, Virum, DenmarkPDB60 NonePDB61 NonePDB62 AstraZeneca, Molndal, SwedenPDB63 Boehringer Ingelheim France, Paris, FrancePDB64 Novartis Farmaceutica S.A., Barcelona, SpainPDB65 None




PDB66 Novo Nordisk, Princeton, NJ, USAPDB67 NonePDB68 The Israel National Institute for Healt Policy Research, Tel Hashomer, IsraelPDB69 NonePDB70 Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USAPDB71 NonePDB72 NonePDB73 NonePDB74 NonePDB75 NonePDB76 NonePDB77 NonePDB78 Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USAPDB79 Eli Lilly and Company, Indianapolis, IN, USAPDB80 NonePDB81 NonePDB82 Novartis Hungary, Budapest, HungaryPDB83 NonePGI1 Bristol-Myers Squibb, Princeton, NJ, USAPGI2 NonePGI3 Bristol-Myers Squibb, Rueil-Malmaison, FrancePGI4 AstraZeneca Turkey, Istanbul, TurkeyPGI5 Almirall S.A., Barcelona, SpainPGI6 UK National Health Service Research & Development Programme Health

Technology Assessment Programme, Southampton, UKPGI7 NonePGI8 NonePGI9 NonePGI10 National Research Foundation (NRF), Pretoria, South AfricaPGI11 NonePGI12 NonePGI13 NonePGI14 Janssen-Cilag, Beerse, BelgiumPGI15 Janssen-Cilag, Tilburg, The NetherlandsPGI16 EPAC ONLUS, Rome, ItalyPGI17 Evidencias, Campinas, BrazilPGI18 Roche Farmaceutica Quımica, Lda., Amadora, PortugalPGI19 NonePGI20 Fresenius Kabi, Moscow, RussiaPGI21 Health and Labour Sciences Research Grants of Ministry of Health, Labor,

and Welfare, Tokyo, JapanPGI22 Shimane University Hospital, Izumo, JapanPGI23 Shire, Wayne, PA, USAPGI24 AstraZeneca R&D, Mölndal, SwedenPGI25 Bristol Myers-Squibb, Princeton, NJ, USAPGI26 Novartis Farmaceutica, S.A., Barcelona, SpainPGI27 Kantar Health, New York, NY, USAPGI28 Shire Development, Inc., Wayne, PA, USAPGI29 NonePGI30 EPAC, Rome, ItalyPGI31 Shire Development, Inc., Wayne, PA, USAPGI32 Norgine, Uxbridge, UKPGI33 German Federal Ministry for Education and Research, Berlin, GermanyPHP1 NonePHP2 NonePHP3 NonePHP4 Ministry of Public Health, Brussels, BelgiumPHP5 NonePHP6 NonePHP7 NonePHP8 Double Helix Consulting, London, UKPHP9 NonePHP10 Novo Nordisk Pharma S.A., Madrid, SpainPHP11 Eucomed, Brussels, BelgiumPHP12 NonePHP13 NonePHP14 NonePHP15 NonePHP16 NonePHP17 NonePHP19 London School of Economics, London, UKPHP20 NonePHP21 LSE, London, UKPHP22 European Commission, Executive Agency for Health and Consumers (EAHC),

Luxembourg, Luxembourg; Austrian Federal Ministry of Health, Vienna,Austria

PHP23 Quintiles, Hawthorne, NY, USAPHP24 NonePHP25 The National Institute for Health Policy, Ramat Gan, IsraelPHP26 NonePHP27 None

PHP28 NonePHP29 GIRP, Brussels, BelgiumPHP30 European Commission (Directorate-General for Enterprise and Industry),

Belgium, BelgiumPHP31 Sanofi-aventis, Paris, FrancePHP32 Bridgehead International, London, UKPHP33 NonePHP34 NonePHP35 NonePHP36 Seventh Framework Programme of the European Community, Brussels,

BelgiumPHP37 Glaxosmithkline, Tres Cantos, SpainPHP38 NonePHP39 Pfizer Korea, Inc., Seoul, South KoreaPHP40 NonePHP41 NonePHP42 NonePHP43 NonePHP44 NonePHP45 NonePHP46 RIZIV, Brussels, BelgiumPHP47 NonePHP48 CARPC, Zagreb, CroatiaPHP49 NonePHP50 NonePHP51 NonePHP52 NonePHP53 Bristol Myers Squibb, Warszawa, PolandPHP54 NonePHP55 Schering Plough, Welwyn Garden City, UKPHP56 NonePHP57 NonePHP58 The University of Sheffield, Sheffield, UKPHP59 Express Scripts, Inc., St. Louis, MO, USAPHP60 Apoteket AB, Stockholm, SwedenPHP61 Valencian Community Government. Health Department, Valencia, Spain;

Universitat Politecnica de Valencia, Valencia, SpainPHP62 NonePHP63 NonePHP64 Health Department of the City of Zurich, Zurich, SwitzerlandPHP65 National Association of Pharmacies (ANF), Lisbon, PortugalPHP66 Fonds de la recherche en sante du Quebec, Montreal, QC, Canada; Pfizer,

Montreal, QC, Canada; sanofi-aventis, Laval, QC, CanadaPHP67 NonePHP68 NonePHP69 NonePHP70 NonePHP71 NonePHP72 International Health Policy Program, Nonthaburi, ThailandPHP73 NonePHP74 NonePHP75 GSK France, Marly Le Roi, FrancePHP76 NonePHP77 NonePHP78 GlaxoSmithKline GmbH&Co. KG, Munich, GermanyPHP79 NonePHP80 NonePHP81 NonePHP82 NonePHP83 Abbott Nutrition International, Maidenhead, UKPHP84 Ministry of Science and Higher Education of the Republic of Poland,

Warsaw, PolandPHP85 Finnish Medicines Agency, Kuopio, FinlandPHP86 NonePHP87 The Commonwealth Fund, New York City, NY, USAPHP88 NonePHP89 NonePHP90 NonePHP91 Ministry of Health, Wealth and Labour, Tokyo, JapanPHP92 NonePHP93 NonePHP94 NonePHP95 NonePHP96 NonePHP97 Ministry of Health, Brussels, BelgiumPHP98 NonePHP99 Sanofi, Paris, FrancePHP100 NonePHP101 NonePHP102 NonePHP103 None




PHP104 Pharmerit International, Rotterdam, The NetherlandsPHP105 Top Institute Pharma, Leiden, The NetherlandsPHP106 Dutch Health Care Insurance Board (CVZ), Diemen, The NetherlandsPHP107 Hellenic Association of Pharmaceutical Companies (SFEE), Athens, GreecePHP108 Pharma.be, Brussels, BelgiumPHP109 NonePHP110 NonePHP111 NonePHP112 NonePHP113 NonePHP114 NonePHP115 NonePHP116 RTI Health Solutions, Research Triangle Park, NC, USA; Eli Lilly and

Company, Indianapolis, IN, USAPHP117 Medical Research Council, London, UKPHP118 NonePHP119 NonePHP120 NonePHP121 NonePHP122 NonePHP123 Costello Medical Consulting, Cambridge, UKPHP124 NonePHP125 NonePHP126 NonePHP127 NonePHP128 Roche, Sao Paulo, BrazilPHP129 NonePHP130 NonePHP131 Double Helix Consulting, London, UKPHP132 Johnson&Johnson Medical, Norderstedt, GermanyPHP133 NonePHP134 NonePHP135 NonePHP136 The Ministry of Science and Technological Development, Beograd, Serbia

and MontenegroPHP137 NonePHP138 NonePHP139 NonePHP140 NonePHP141 NonePHP142 NonePHP143 NonePHP144 NonePHP145 Costello Medical Consulting, Cambridge, UKPHP146 General Electric Co., Fairfield, CT, USA; Eli Lilly & Co, Indianapolis, IN, USA;

Novartis AG, Basel, Switzerland; F. Hoffmann-La Roche Ltd., Basel,Switzerland; Johnson and Johnson Services, Inc., New Brunswick, NJ, USA;Glaxo- SmithKline plc, Middlesex, UK; Sanofi-aventis, Paris, France; PfizerInc., New York, NY, USA; Amgen Inc., Thousand Oaks, CA, USA; GenentechInc., South San Francisco, CA, USA; Merck & Co, Inc., Whitehouse Station,NJ, USA; Bayer HealthCare Pharmaceuticals Inc, Wayne, NJ, USA; JanssenAI, South San Francisco, CA, USA; Allergan, Irvine, CA, USA

PHP147 NonePHP148 IHS, Denver, CO, USAPHP149 NonePHP150 NonePHP151 LSE Health, London, UK; European Commission, Brussels, BelgiumPHP152 Costello Medical Consulting, Cambridge, UKPHP153 NonePHP154 Tehran University of Medical Sciences, Tehran, IranPHP155 NonePHP156 NonePHP157 NonePHP158 NonePHP159 ONCOTYROL - Center for Personalized Cancer Medicine GmbH, Innsbruck,

Austria; Austrian Federal Ministry for Science and Research, Vienna, AustriaPHP160 European Medicines Agency, London, UKPHP161 Lilly, Moscow, RussiaPHP162 NonePHP163 NonePHP164 NonePHP165 NonePHP166 Double Helix Consulting, London, UKPHP167 NonePHP168 NonePHP169 NonePIH1 Teva Pharmaceuticals, Kansas City, MO, USAPIH2 Abbott Laboratories Limited, Saint-Laurent, QC, CanadaPIH3 Abbott Laboratories Limited, Saint-Laurent, QC, CanadaPIH4 Abbott Laboratories Limited, saint-Laurent, QC, CanadaPIH5 Abbott Laboratories Limited, Saint-Laurent, QC, Canada

PIH6 NonePIH7 NonePIH8 NonePIH9 NonePIH10 NonePIH12 PFSA, Boulogne, FrancePIH13 GlaxoSmithKline Biologicals, Wavre, BelgiumPIH14 NonePIH15 NonePIH16 NonePIH17 Bayer Schering Pharma, Berlin, GermanyPIH18 Sanofi Pasteur MSD, Maidenhead, UKPIH19 GlaxoSmithKline Biologics, Wavre, BelgiumPIH20 World Endometriosis Research Foundation, London, UKPIH21 GlaxoSmithKline Biologicals, Wavre, BelgiumPIH22 Pfizer, Beijing, China; Pfizer, New York, NY, USAPIH23 Shire Pharmaceuticals, Wayne, PA, USAPIH24 Bayer, Sao Paulo, BrazilPIH25 Instituto de Salud Carlos III, Madrid, SpainPIH26 Bayer Korea Ltd., Seoul, South KoreaPIH27 GlaxoSmithKline, Mississauga, ON, CanadaPIH28 GlaxoSmithKline, Buenos Aires, ArgentinaPIH29 German Research Foundation (DFG), Berlin, Germany; federal Ministry for

Education and Research (BMBF), Berlin, GermanyPIH30 Bayer, Bratislava, Slovak RepublicPIH31 Merck Sharp & Dohme, Sydney, AustraliaPIH32 Registrat Mapi, Lyon, FrancePIH33 NonePIH35 NonePIH36 Thai Health Promotion Foundation, Bangkok, ThailandPIH37 NonePIH38 NonePIH39 Pfizer Ltd., Tadworth, UKPIH40 Shire HGT, Cambridge, MA, USAPIH41 NonePIH42 PFSA, Boulogne, FrancePIH43 Fondo de Investigacion Sanitaria, Madrid, SpainPIH44 QualityMetric Incorporated, Lincoln, RI, USAPIH45 Sanofi Pasteur MSD, Maidenhead, UKPIH46 NonePIH47 NonePIH48 Bayer Schering Pharma, Berlin, GermanyPIH49 PFSA, Boulogne, FrancePIH50 NonePIH51 Federal Ministry of Education and Research, Berlin, GermanyPIH52 NonePIH53 Eli Lilly, Indianapolis, IN, USAPIH54 NonePIH55 Shiraz University of Medical Sciences, Shiraz, IranPIH56 NonePIH57 Service Public Federal Sante Publique, Brussels, BelgiumPIH59 NonePIH60 NonePIH61 NonePIH62 NonePIH63 Pfizer, New York, NY, USAPIH64 Ethicon, Germany, GermanyPIH65 GlaxoSmithKline Biologicals, Wavre, BelgiumPIH66 NonePIH67 Pfizer, New York, NY, USAPIH68 Bayer Schering Pharm, Berlin, GermanyPIN1 NonePIN2 Gilead Sciences, Warsaw, PolandPIN3 Bristol-Myers Squibb, rueil-Malmaison, FrancePIN4 Pfizer Inc, New York, NY, USAPIN5 Novartis Pharmaceuticals Australia, North Ryde, AustraliaPIN6 Bristol Myers Squibb, Istanbul, TurkeyPIN7 Janssen Pharmaceutica NV, Beerse, BelgiumPIN8 Bristol Myers Squibb, Istanbul, TurkeyPIN9 NonePIN10 Pfizer Inc, New York, NY, USAPIN11 Bristol Myers Squibb, Princeton, NJ, USAPIN12 Pfizer, Collegeville, PA, USAPIN13 NonePIN14 Novartis Pharma, Basel, SwitzerlandPIN15 NonePIN16 NonePIN17 Sanofi Pasteur MSD, Lyon, FrancePIN18 Gilead, Warszawa, PolandPIN19 Roche, Moscow, RussiaPIN20 Pfizer SLU, Madrid, Spain




PIN21 Bayer HealthCare Pharma, Moscow, RussiaPIN22 NonePIN23 Abbott SpA, Campoverde di Aprilia, ItalyPIN24 NonePIN26 Abbott Laboratories, Abbott Park, IL, USAPIN27 NonePIN28 NonePIN29 Pfizer Pharmaceutics Inc., Sao Paulo, BrazilPIN30 Pfizer Inc, New York, NY, USAPIN31 Pfizer Inc., New York, NY, USAPIN32 Bayer HealthCare Pharmaceuticals, Wayne, NJ, USA; Bayer Schering

Pharma, Berlin, GermanyPIN33 NonePIN34 The Netherlands Vaccine Institute (NVI), Bilthoven, The NetherlandsPIN35 sanofi-pasteur MSD, Maidenhead, UKPIN36 Ethicon, JNJ, Somerville, NJ, USAPIN37 Janssen AB, Sollentuna, SwedenPIN38 Deutsche Leberstiftung, Hannover, GermanyPIN39 NonePIN40 Pfizer Pharmaceutics Inc., Sao Paulo, BrazilPIN41 NonePIN42 National Health and Medical Research Council (NHMRC) Australian-based

Public Health Training Fellowship (630724), Canberra, AustraliaPIN43 Abbott Srl, Campoverde di Aprilia (LT), ItalyPIN44 Sanofi Pasteur MSD, Lyon, FrancePIN46 Pfizer, Kuala Lumpur, MalaysiaPIN47 NonePIN48 NonePIN49 Pfizer Inc., New York, NY, USAPIN50 Merck & Co, Whitehouse Station, NJ, USAPIN51 Pfizer, San Jose, Costa RicaPIN52 Pfizer Inc., New York, NY, USAPIN53 Roche Polska Sp. z o.o., Warsaw, PolandPIN54 Pfizer Canada, Inc., Kirdland, QC, CanadaPIN55 NonePIN56 Roche Farma, Madrid, SpainPIN57 Pfizer Inc., New York, NY, USAPIN58 Pfizer, Sao Paulo, BrazilPIN59 p, San Jose, Costa RicaPIN60 NonePIN61 Janssen-cilag, Sao Paulo, BrazilPIN62 Roche Farma, Madrid, SpainPIN63 Pfizer, San Jose, Costa RicaPIN64 Pfizer, San Jose, Costa RicaPIN65 GlaxoSmithKline GmbH, Munich, GermanyPIN66 Janssen Cilag Farmaceutica, Sao Paulo, BrazilPIN67 NonePIN68 Merck & Co., Inc, Moscow, RussiaPIN69 Sanofi Pasteur MSD, Lyon, FrancePIN70 Sanofi Pasteur, Lyons, FrancePIN71 Bayer HealthCare Pharma, Moscow, RussiaPIN72 Dutch Higher Education, Den Haag, The NetherlandsPIN73 Bristol-Myers Squibb, Rueil-Malmaison, FrancePIN74 Sanofi Pasteur MSD, Lyon, FrancePIN75 Sanofi Pasteur, Lyon, FrancePIN76 Pfizer Pharmaceutics Inc., Sao Paulo, BrazilPIN77 Astellas Pharma Europe Ltd., Staines, UKPIN78 NonePIN79 Gilead, Warszawa, PolandPIN80 AstraZeneca, Wedel, GermanyPIN81 Shanghai Roche, Shanghai, ChinaPIN82 Bristol-Myers Squibb, Mu, GermanyPIN83 Roche Polska Sp. z o.o., Warsaw, PolandPIN84 Abbott SpA, Campoverde di Aprilia, ItalyPIN85 NonePIN86 Fundacio IMIM, Barcelona, SpainPIN87 Janssen Cilag Farmaceutica, Sao Paulo, BrazilPIN88 NonePIN89 Bristol-Myers Squibb, Paris, FrancePIN90 Janssen Cilag, Neuss, GermanyPIN91 NonePIN92 Roche, Madrid, SpainPIN93 NonePIN94 NonePIN95 Instituto de Salud Carlos III, ISCIII GR09/0026, Madrid, SpainPIN96 Institute for Health Management, National Institutes of Health, Ministry of

Health, Kuala Lumpur, MalaysiaPIN97 NonePIN98 BMS, Princeton, NJ, USAPIN99 NonePIN100 None

PIN101 NonePIN102 NonePIN103 Abbott Italia Srl, Campoverde di Aprilia, ItalyPIN104 NonePIN105 NonePIN106 NonePIN107 Novartis Canada, Montreal, QC, CanadaPIN108 Janssen-Cilag GmbH, 41470 Neuss, GermanyPIN109 2GlaxoSmithKline Biologicals, Wavre, BelgiumPIN110 CRUCELL, Berne, SwitzerlandPIN111 NonePIN112 Pfizer SLU, Madrid, SpainPIN113 ANRS, Paris, France; Health Secretariat of the State of Sao Paulo, Sao

Paulo, Brazil; DRCD, Paris, FrancePMD1 alcon france, Rueil-Malmaison, FrancePMD2 National Institute for Health Research (NIHR) Health Technology Appraisal

programme, Southampton, UKPMD3 National Institute for Health Research (NIHR) Health Technology Programme,

Southampton, UKPMD4 NonePMD5 National Institute for Health Research (NIHR) Health Technology Programme,

Southamptom, UKPMD6 Medtronic International, Tolochenaz, SwitzerlandPMD7 Roche Diagnostics, Mannheim, GermanyPMD8 NonePMD9 Bayer, Sao Paulo, BrazilPMD10 St. Jude Medical, St. Paul, MN, USAPMD11 Medtronic, Madrid, SpainPMD12 Johnson&Johnson Medical, Madrid, SpainPMD13 Cordis Corporation, Bridgewater, NJ, USAPMD14 Cordis Corporation, Bridgewater, NJ, USAPMD15 Biotronik SE & Co KG, Berlin, GermanyPMD16 Novartis, Basel, SwitzerlandPMD17 NonePMD18 Medtronic International, Tolochenaz, SwitzerlandPMD19 NonePMD20 Medtronic, France, FrancePMD21 MEDTRONIC ITALIA, Milan, ItalyPMD22 Johnson & Johnson, Madrid, SpainPMD23 The Netherlands Organisation for Health Research and Development, The

Hague, The NetherlandsPMD24 3M Skin & Wound Care Division, Neuss, GermanyPMD25 Edwards Lifesciences, Milano, ItalyPMD27 Medtronic, Madrid, SpainPMD28 Netherlands Leprosy Relief Agency, Jos, NigeriaPMD29 Bayer, Sao Paulo, BrazilPMD30 Medtronic International Trading Sarl, Tolochenaz, SwitzerlandPMD31 Bayer, Barcelona, SpainPMD32 NonePMD33 NonePMD34 MITACS, Hamilton, ON, CanadaPMD35 Johnson & Johnson Medical, Madrid, SpainPMD36 alcon france, Rueil-malmaison, FrancePMD37 alcon france, Rueil-malmaison, FrancePMD38 Critical Diagnostics, San Diego, CA, USAPMD39 NonePMD40 St. Jude Medical, St. Paul, MN, USAPMD41 NonePMD42 Ministry of Higher Education, Kuala Lumpur, MalaysiaPMD43 Therakos, Madrid, SpainPMD44 Ministry of Higher Education, Kuala Lumpur, MalaysiaPMD45 Medtronic International Sarl, Tolochenaz, SwitzerlandPMD46 Apex Pharma Kft., Budapest, HungaryPMD48 HeartWare Inc., Framingham, MA, USAPMD49 NIHR, HTA programme, London, UKPMD50 NonePMD51 Bayer HealthCare Pharmaceuticals, Berlin, GermanyPMD52 Biotronik SE & Co KG, Berlin, GermanyPMD53 Medtronic France SAS, Boulogne Billancourt, FrancePMD54 AstraTech, Mölndal, SwedenPMD55 AstraTech, Mölndal, SwedenPMD56 Baxter Healthcare, Westlake Village, CA, USAPMD57 GE HealthCare, Chalfont St Giles, UKPMD58 German Federal Ministry of Education and Research, Berlin, GermanyPMD59 Medtronic, Tolochenaz, SwitzerlandPMD60 GlaxoSmithKline, Research Triangle Park, NC, USAPMD61 Taipei City Hospital, Taipei, Taiwan; Buddhist Tzu Chi General Hospital,

Taipei Branch, New Taipei, TaiwanPMD62 Astellas, Deerfield, IL, USAPMD63 Bayer Korea, Seoul, South KoreaPMD64 None




PMD65 NonePMD66 Biotronik SE & Co KG, Berlin, GermanyPMD67 Edwards Lifesciences, Newbury, UKPMD68 Abbott Vascular, Santa Clara, CA, USAPMD69 AstraTech, Mölndal, SwedenPMD70 NonePMD71 Biotronik SE & Co KG, Berlin, GermanyPMD72 NonePMD73 National Institutes of Health, Bethesda, NM, USAPMD74 Baxter Healthcare Corporation, Braine l’Alleud, BelgiumPMD75 Roche Diagnostics, Bratislava, Slovak RepublicPMD76 Quintiles, Hoofddorp, The NetherlandsPMD77 NonePMD78 ZonMW, Den Haag, The NetherlandsPMD79 Center for Translational Molecular Medicine (CTMM), Eindhoven,

Netherlands; Netherlands Heart Foundation, The Hague, The NetherlandsPMD80 ETHICON, Livingston, UKPMD81 Center for Translational Molecular Medicine, Eindhoven, The NetherlandsPMD82 Medtronic, Milan, ItalyPMD83 The National Institute for Health Research Health Technology Assessment,

Southampton, UKPMD84 NonePMD85 Pfizer Inc., New York, NY, USAPMD86 NonePMH1 NonePMH2 University of the Basque Country, UPV/EHU, Leioa, SpainPMH3 Eli Lilly and Company, Indianapolis, IN, USAPMH4 Eli Lilly and Company, Indianapolis, IL, USAPMH5 Eli Lilly and Company, Indianapolis, IN, USAPMH6 Janssen, Neuss, GermanyPMH7 Lundbeck SAS, Issy les Moulineaux, FrancePMH8 NonePMH9 National Research Foundation (NRF), Pretoria, South AfricaPMH10 Florida Agency for Health Care Administration, Tallahassee, FL, USAPMH11 University of Utah Interdisciplinary Seed Grant, Salt Lake City, UT, USAPMH12 Eli Lilly and Company, Indianapolis, IN, USAPMH13 Eli Lilly and Company, Indianapolis, IN, USAPMH14 TEVA Innovative Espana, Madrid, SpainPMH15 Bayer HealthCare Pharmaceuticals, Berlin, GermanyPMH16 Reckitt Benckiser Pharmaceuticals, Madrid, SpainPMH17 AstraZeneca, Warsaw, PolandPMH18 AstraZeneca, Warsaw, PolandPMH19 Janssen Pharmaceuticals, Birkerød, DenmarkPMH20 NonePMH21 Washington State Division of Alcohol and Substance Abuse, Olympia, WA,

USAPMH22 NonePMH23 NonePMH24 NonePMH25 NonePMH26 Genome Quebec, Montreal, QC, Canada; Genome Canada, Montreal, QC,

CanadaPMH27 Reckitt Benckiser, Slough, UKPMH29 AstraZeneca, Istanbul, TurkeyPMH31 Eli Lilly (HTA ACE-J Group), Indianapolis, IN, USAPMH32 NonePMH33 Janssen, Madrid, SpainPMH34 Sanofi, Warszawa, PolandPMH35 Janssen Pharmaceutica, Beerse, BelgiumPMH36 Bayer Vital GmbH, Leverkusen, GermanyPMH37 Lundbeck SAS, Issy-les-Moulineaux, FrancePMH38 Reckitt Benckiser Healthcare (Italy) SpA – Drug Business Unit., Milan, ItalyPMH39 ZonMW , Den Haag, The NetherlandsPMH40 Servier Laboratories (Aust) Pty Ltd., Hawthorn, AustraliaPMH42 Janssen Korea, Seoul, South KoreaPMH43 Takeda Pharmaceutical Company, Deerfield, IL, USAPMH44 Advanced Pain Centers, S.C., Hoffman Estates, IL, USAPMH45 NonePMH46 Janssen-Cilag B.V., Tilburg, The NetherlandsPMH47 Novartis Farmaceutica, S.A., Barcelona, SpainPMH48 AstraZeneca, Madrid, SpainPMH49 Astrazeneca, Wilmington, DE, USAPMH50 Reckitt Benckiser Pharmaeuticals, Richmond, VA, USAPMH51 NonePMH52 NonePMH53 Instituto Salud Carlos III. FIPSE 3035/99, FIS 00/1017, Madrid, Spain; DIUE

Generalitat de Catalunya. 2009 SGR 718, Barcelona, SpainPMH54 NonePMH55 Takeda Pharmaceutical Company, Deerfield, IL, USAPMH56 Roche, Basel, SwitzerlandPMH57 Takeda Pharmaceutical Company, Deerfield, IL, USA

PMH58 Pfizer, Madrid, SpainPMH59 Eli Lilly and Company, Indianapolis, IN, USAPMH60 Lundbeck, Issy-les-Moulineaux, FrancePMH61 Shire Pharmaceuticals, Inc, Wayne, PA, USAPMH62 Takeda Pharmaceutical Company, Deerfield, IL, USAPMH63 NonePMH64 NHRI, Jhunan, TaiwanPMH65 AstraZeneca, Södertälje, SwedenPMH66 NonePMH67 IMS Health Sweden AB, Stockholm, SwedenPMH68 AstraZeneca, Södertälje, SwedenPMH69 ”Prends soin de toi” Program, Montreal, QC, CanadaPMH70 Glaxosmithkline, Paris, FrancePMH71 AstraZeneca Pharmaceuticals, L.P, Wilmington, DE, USAPMH72 AstraZeneca Pharmaceuticals, LP, Wilmington, DE, USAPMH73 vdek Baden-Wuerttemberg, Stuttgart, Germany; KV BaWue,

Stuttgart/Karlsruhe, GermanyPMH74 Universitat Politecnica de Valencia, Valencia, SpainPMH75 Reckitt Benckiser Pharmaeuticals, Richmond, VA, USAPMH76 Lundbeck A/S, Copenhagen, DenmarkPMH77 Manipal University, Manipal, India; Association of Community

Pharmacists of India, Manipal, IndiaPMH78 Manipal University, Manipal, India; ACPI, Manipal, IndiaPMH79 National Institute of Mental Health, Bethesda, MD, USAPMH80 Lundbeck SAS, Issy-les-Moulineaux, FrancePMH81 Lundbeck, Hamburg, GermanyPMH82 NonePMH83 NonePMH84 Pfizer, Madrid, SpainPMS1 NonePMS2 AHW, Edmonton, AB, CanadaPMS3 Eli Lilly and Company, Indianapolis, IN, USAPMS4 Auxilium, Malvern, PA, USAPMS5 NonePMS6 Roche, Woerden, The NetherlandsPMS7 NonePMS8 Eli Lilly and Company, Indianapolis, IN, USAPMS9 DePuy Mitek, Inc., Raynham, MA, USAPMS10 NonePMS11 Pfizer, Rome, ItalyPMS12 BristolMeyerSquibb Italia, Rome, ItalyPMS13 Pfizer, Moscow, RussiaPMS14 Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by

Wyeth, which was acquired by Pfizer Inc. in October 2009, Thousand Oaks,CA, USA

PMS15 Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and byWyeth, which was acquired by Pfizer Inc. in October 2009, Thousand Oaks,CA, USA

PMS16 Janssen-Cilag, Neuss, GermanyPMS17 NonePMS18 NonePMS19 Amgen Hellas, Marousi, GreecePMS20 NonePMS21 Ministry of Health and Welfare, Seoul, South KoreaPMS22 Amgen Canada Inc., Mississauga, ON, CanadaPMS23 Ministry of Health, Labor and Welfare, Tokyo, JapanPMS24 Abbott Labs, Istanbul, TurkeyPMS25 NonePMS26 Pfizer, New York, NY, USAPMS27 Amgen CEE HO, Vienna, AustriaPMS28 Amgen CEE HO, Vienna, AustriaPMS29 Bristol-Myers Squibb, Rueil Malmaison, FrancePMS30 Roche Farmaceutica Quımica, Lda., Amadora, PortugalPMS31 Bristol Myers Squibb Pharmaceuticals, London, UKPMS32 Pfizer Brazil, Sao Paulo, BrazilPMS33 NonePMS34 UCB Mexico, Mexico, MexicoPMS35 Amgen Hellas, Athens, GreecePMS36 Pfizer Brazil, Sao Paulo, BrazilPMS37 HFA Healthcare, Birmingham, UKPMS38 MedImmune LCC, Gaithersburg, MD, USAPMS39 NonePMS40 Pfizer Brazil, Sao Paulo, BrazilPMS41 MSD Australia, Sydney, AustraliaPMS42 NonePMS43 Pfizer Portugal, Lisbon, PortugalPMS44 Amgen, Cambridge, UKPMS45 UCB, Bruxelles, BelgiumPMS46 UCB, Madrid, SpainPMS47 Merck, Whitehouse Station, NJ, USAPMS48 Amgen, Barcelona, Spain




PMS49 Roche, Woerden, The NetherlandsPMS50 NonePMS51 NonePMS52 NonePMS53 NonePMS54 NonePMS55 NonePMS56 Centre for Public Affairs Studies Foundation, Budapest, Hungary; Roche

Hungary, Budapest, Hungary; TAMOP 4.2.1/B-09/1/KMR-2010-0005,Budapest, Hungary

PMS57 Eli Lilly and Company, Indianapolis, IN, USAPMS58 Eli Lilly and Company, Indianapolis, IN, USAPMS59 Merck & Co., Inc., Whitehouse Station, NJ, USAPMS60 Eli Lilly and Company, Indianapolis, IN, USAPMS61 UCB, Brussels, BelgiumPMS62 Celgene Corporation, Warren, NJ, USAPMS63 USB, Monheim, GermanyPMS64 Pfizer, Tadworth, UKPMS65 Graduate School of Chulalongkorn University, Bangkok, ThailandPMS66 Eli Lilly and Company, Indianapolis, IN, USAPMS67 NonePMS68 Abbott Greece, Athens, GreecePMS69 NonePMS70 Eli Lilly and Company, Indianapolis, IN, USAPMS71 NonePMS72 Eli Lilly and Company, Indianapolis, IN, USAPMS73 Pfizer, Moscow, RussiaPMS74 NonePMS75 Merck, Sharp & Dohme, Paco de Arcos (Oeiras), PortugalPMS76 DePuy Mitek, Inc., Raynham, MA, USAPMS77 Washington State Department of Labor and Industries, Olympia, WA, USAPMS78 Medtronic Inc, Tolochenaz, SwitzerlandPMS79 Bristol Myers Squibb Pharmaceuticals, London, UKPND1 Biogen Idec, Wellesley, MA, USAPND2 Teva Neuroscience Inc, Hersham, PA, USAPND3 TEVA Pharma SLU, Madrid, SpainPND4 NonePND5 NonePND6 NonePND7 NOVARTIS PHARMA AG, Basel, SwitzerlandPND8 PFSA, Boulogne, FrancePND9 TEVA Innovative Espana, Madrid, SpainPND10 Biogen Idec, Weston, MA, USAPND11 TEVA Pharma, Madrid, SpainPND12 GlaxoSmithKline, Research Triangle Park, NC, USA; Human Genome

Services, Rockville, MD, USAPND13 GlaxoSmithKline, Marly le Roi, FrancePND14 Instituto de Salud Carlos III, Madrid, SpainPND15 Allergan Singapore, Singapore, SingaporePND16 Novartis Slovakia, Bratislava, Slovak RepublicPND17 Novartis Pharmaceuticals, Basel, SwitzerlandPND18 GlaxoSmithKline, Research Triangle Park, NC, USAPND19 NonePND20 NonePND21 NonePND22 NonePND23 NonePND24 NonePND25 Laboratoire GlaxoSmithKline, Marly le Roi, FrancePND26 Teva Pharmaceuticals, Kansas City, MO, USAPND27 IPSEN, Paris, FrancePND28 TEVA PHARMA, MADRID, SpainPND29 NonePND30 Almirall, Barcelona, SpainPND31 Shire Australia Pty Limited, North Ryde, Sydney, AustraliaPND32 GSK, Warszawa, PolandPND33 Novartis Pharma B.V, Arnhem, The NetherlandsPND34 UCB, Brussels, BelgiumPND35 Novartis, Vilvoorde, BelgiumPND36 sanofi-aventis, Bridgewater, NJ, USAPND37 Teva Pharmaceuticals, Kansas City, MO, USAPND38 Neurosearch, Copenhagen, DenmarkPND39 Shire Australia Pty Ltd., North Ryde, Sydney, AustraliaPND40 Merck & Co., Inc, West Point, PA, USAPND41 NonePND42 Sanofi-aventis, Bridgewater, NJ, USAPND43 Astellas Pharma Global Development, Leiderdorp, The NetherlandsPND44 Shire, Cambridge, MA, USAPND45 PatientsLikeMe, Inc., Cambridge, MA, USA; Novartis Pharmaceuticals

Corporation, East Hanover, NJ, USAPND46 Neurosearch, Copenhagen, Denmark

PND47 Neurosearch, Copenhagen, DenmarkPND48 PFSA, Boulogne, FrancePND49 NonePND50 University of Georgia, College of Pharmacy, Department of Clinical and

Administrative Pharmacy, Athens, GA, USAPND51 Allergan, Irvine, CA, USAPND52 Merck Serono, Geneva, SwitzerlandPND53 Biogen Idec, Weston, MA, USAPND54 Medtronic International Trading Sarl, Tolochenaz, SwitzerlandPND55 NonePND56 NonePND57 Bayer HealthCare Pharmaceuticals, Wayne, NJ, USAPND58 Shire HGT, Basingstoke, UKPND59 NonePND60 Teva Pharmaceuticals, Kansas City, MO, USAPND61 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USAPND62 NonePND63 GlaxoSmithKline GmbH & Co. KG, Munich, GermanyPND64 Bayer HealthCare, Wayne, NJ, USAPND65 NonePND66 CAPES, Ribeirao Preto, BrazilPND67 NonePND68 EAHC, Luxembourg, LuxembourgPRM1 NonePRM2 Novartis Pharmaceuticals, Barcelona, SpainPRM3 NonePRM4 NonePRM5 NonePRM6 NonePRM7 NonePRM8 Chulalongkorn University, Bangkok, ThailandPRM9 Costello Medical Consulting, Cambridge, UKPRM10 NonePRM11 Symmetron limited, Elstree, UKPRM12 NonePRM13 NonePRM14 TI Pharma, Leiden, The Netherlands; Utrecht University, Utrecht, The

Netherlands; University Medical Center Utrecht, Utrecht, The Netherlands;GSK, Zeist, The Netherlands; University Medical Center Groningen,Groningen, The Netherlands; Groningen University, Groningen, TheNetherlands; Sanofi-Aventis, Gouda, The Netherlands

PRM15 NonePRM16 NonePRM17 Departament de Salut de la Generalitat de Catalunys, Barcelona, Spain;

AGAUR (2009 SGR 1095), Barcelona, SpainPRM18 NonePRM19 Double Helix Consulting, London, UKPRM20 NonePRM21 NonePRM22 NonePRM23 UK NHS Health Technology Assessment (HTA) Programme, Southampton,

UKPRM24 NonePRM25 Sanofi-aventis, Paris, FrancePRM26 the university of Sheffield, Sheffield, UKPRM27 NonePRM28 HTA Consulting, Krakow, PolandPRM29 NonePRM30 PatientsLikeMe, Cambridge, MA, USAPRM31 NonePRM32 ZonMW, The Hague, The NetherlandsPRM33 Instituto de Salud Carlos III, Madrid, SpainPRM34 NonePRM35 NonePRM36 NonePRM37 NonePRM38 University of Sheffield, Sheffield, UKPRM39 NonePRM40 NonePRM41 University of Sheffield, Sheffield, UKPRM42 NonePRM43 Almac Clinical Technologies, Souderton, PA, USAPRM44 NonePRM45 NonePRM46 NonePRM47 NonePRM48 NonePRM49 NonePRM50 NonePRM51 HealthCore, Inc., Wilmington, DE, USAPRM52 Beca Chile, Santiago, Chile




PRM53 NonePRM54 Thomson Reuters, Washington, DC, USAPRM55 NonePRM56 NonePRM57 NonePRM58 NonePRM59 NonePRM60 Bristol-Myers Squibb, Lawrenceville, NJ, USAPRM61 NonePRM62 National Institute for Health Research, London, UKPRM63 GlaxoSmithKline Biologicals, Wavre, BelgiumPRM64 NonePRM65 NonePRM66 NonePRM67 NonePRM68 Hospital Quiron Bizkaia, Bilbao, SpainPRM69 NonePRS1 Pfizer Pharmaceutics Inc., Sao Paulo, BrazilPRS2 Adheris, Inc., Burlington, MA, USAPRS3 Talecris Biotherapeutics, Frankfurt, GermanyPRS4 Instituto de Salud Carlos III, Madrid, SpainPRS5 Roche Polska Sp. z o.o., Warsaw, PolandPRS6 Boehringer Ingelheim GmbH, Ingelheim, GermanyPRS7 Pfizer Brazil, Sao Paulo, BrazilPRS8 Vertex Pharmaceuticals Incorporated, Cambridge, MA, USAPRS9 Stallergenes GmbH, Kamp-Lintfort, GermanyPRS10 ALK-Abello, Hørsholm, DenmarkPRS11 Stallergenes, Kamp-Lintfort, GermanyPRS12 Chiesi Espana SA, Barcelona, SpainPRS13 Allergopharma, Reinbek, GermanyPRS14 novartis, Sao Paulo, BrazilPRS15 Novartis, Sao Paulo, BrazilPRS16 Nycomed Pharma, Madrid, SpainPRS17 Basilea Pharmaceutica Ltd., Basel, SwitzerlandPRS18 Vertex Pharmaceuticals Incorporated, Cambridge, MA, USAPRS19 Oblikue Consulting, Barcelona, SpainPRS20 AstraZeneca AB, Södertälje, SwedenPRS21 Pfizer SLU, Madrid, SpainPRS22 NonePRS23 Vertex Pharmaceuticals Incorporated, Cambridge, MA, USAPRS24 Pfizer SLU, Madrid, SpainPRS25 GlaxoSmithKline, Uxbridge, UKPRS26 NonePRS27 Cegedim Strategic Data Medical Research Ltd., London, UKPRS28 Novartis, East Hanover, NJ, USAPRS29 NonePRS30 Novartis Pharmaceuticals Australia, North Ryde, AustraliaPRS31 Novartis, Sao Paulo, BrazilPRS32 Novartis Pharma BV, Arnhem, The NetherlandsPRS33 Pfizer Hellas, Athens, GreecePRS34 Nycomed Pharma S.A., Madrid, SpainPRS35 Novartis, Athens, GreecePRS36 Chiesi Farmaceutici, Parma, ItalyPRS37 GlaxoSmithKline, Moscow, RussiaPRS38 Nycomed, Stockholm, SwedenPRS39 Nycomed Pharma AG, Dubendorf, SwitzerlandPRS40 GSK, Warszawa, PolandPRS41 Stallergenes GmbH, Kamp-Lintfort, GermanyPRS42 NonePRS43 NonePRS44 NonePRS45 MSD Ltd., Hoddesdon, UKPRS46 Organisation Pneumologique pour la Recherche et l’Amelioration des Soins

(OPRAS), Paris, FrancePRS47 GlaxoSmithKline, Moscow, RussiaPRS48 Pfizer, San Jose, Costa RicaPRS49 NonePRS50 Novartis Pharma B.V., Arnhem, The NetherlandsPRS51 Forest Research Institute, Jersey City, NJ, USAPRS52 ZonMW, The Hague, The NetherlandsPRS53 Novartis Pharmaceuticals UK Limited, Camberley, UKPRS54 GlaxoSmithKline, Uxbridge, UKPRS55 Novartis Pharmaceuticals UK Limited, Camberley, UKPRS56 Boehringer Ingelheim GmbH, Ingelheim am Rhein, GermanyPRS57 GlaxoSmithKline Slovakia, Bratislava, Slovak RepublicPRS58 NonePRS59 Novartis Pharmaceuticlas, Barcelona, SpainPRS60 Novartis Pharmaceuticals, Barcelona, SpainPRS61 NonePRS62 NonePRS63 None

PRS64 NonePRS65 Novartis Pharmaceuticals UK Limited, Frimley, UKPRS66 NonePRS67 Bayer Schering Pharma, Diegem, BelgiumPRS68 Johnson and Johnson Medical Asia-Pacific, Singapore, SingaporePRS69 NonePRS70 Pfizer UK Ltd., Tadworth, Surrey, UKPRS71 Pfizer Global Pharmaceuticals, New York, NY, USAPRS72 GlaxoSmithKline, Verona, ItalyPRS73 Nestle Nutrition Institute, Vevey, SwitzerlandPRS74 NonePRS75 NonePRS76 GlaxoSmithKline, London, UKPRS77 Novartis, Horsham, UKPR1 Novo Nordisk, Søborg, DenmarkPR2 NonePR3 NonePR4 Commonwealth Fund, New York, NY, USAPSS1 alcon france, rueil-malmaison, FrancePSS2 Novartis Pharmaceuticals Canada Inc, Dorval, QC, CanadaPSS3 Novartis Pharmaceuticals Canada Inc, Dorval, QC, CanadaPSS4 ALCON, Puurs, BelgiumPSS5 ALCON, Puurs, BelgiumPSS6 Bayer Korea, Seoul, South KoreaPSS7 Novartis Pharma A.G., Basel, SwitzerlandPSS8 Bristol-Myers Squibb, Uxbridge, UKPSS9 Novartis Pharma B.V., Arnhem, The NetherlandsPSS10 ALCON, Puurs, BelgiumPSS11 NonePSS12 Novartis Pharmaceuticals Canada Inc, Dorval, QC, CanadaPSS13 Celgene Corporation, Summit, NJ, USAPSS14 Basilea Pharmaceutica International Ltd., Basel, SwitzerlandPSS15 NonePSS16 Novartis, Vienna, AustriaPSS17 Novartis Hungary, Budapest, HungaryPSS18 Allergan Pharmaceuticals Ireland, Westport, IrelandPSS19 ALCON, Puurs, BelgiumPSS20 Abbott Laboratories, Madrid, SpainPSS21 Janssen-Cilag A/S, Birkeröd, DenmarkPSS22 NonePSS23 Nestle Nutrition Institute, Vevey, SwitzerlandPSS24 Janssen, Moscov, RussiaPSS25 Allergan EAME, Marlow, UKPSS26 Allergan EAME, Marlow, UKPSS27 Eye Hospital, Rotterdam, The NetherlandsPSS28 Bristol-Myers Squibb, Plainsboro, NJ, USAPSS29 Celgene Corporation, Summit, NJ, USAPSS30 Novartis AG, Basel, SwitzerlandPSS31 Basilea Pharmaceutica Ltd., Basel, SwitzerlandPSS32 Alcon Research Ltd., Basel, SwitzerlandPSS33 Basilea, Basel, SwitzerlandPSS34 Alcon Laboratories, Fort Worth, TX, USAPSS35 Alcon Laboratories, Fort Worth, TX, USAPSS36 Genentech, Inc, South San Francisco, CA, USAPSS37 GSK, Wavre, BelgiumPSS38 PFSA, Boulogne, FrancePSS39 NonePSS40 GSK Biologicals, Wavre, BelgiumPSS41 MSD, Madrid, SpainPSS42 Italian Drug Agency (AIFA), Rome, ItalyPSS43 Merck Sharp & Dohme (Australia) Pty Limited, North Ryde, Sydney, AustraliaPSS44 NonePSS45 Janssen-Cilag, Stockholm, SwedenPSS46 Novartis Farmaceutica, S.A., Barcelona, SpainPSU1 NonePSU2 Novartis Pharmaceutical Corporation, East Hanover, NJ, USAPSU3 Novartis Pharmaceutical Corporation, East Hanover, NJ, USAPSU4 Novartis Pharmaceutical Corporation, East Hanover, NJ, USAPSU5 NonePSU6 alcon france, Rueil-malmaison, FrancePSU7 NonePSU8 Alcon research Ltd., Puurs, BelgiumPSU9 Amgen, Inc., Thousand Oaks, CA, USAPSU10 Philips Healthcare, Hamburg, GermanyPSU11 Baxter, Maurepas, FrancePSU12 Abbott Laboratories, Abbott Park, IL, USAPSU13 Pfizer S.L.U, Madrid, SpainPSU14 Teva Pharmaceuticals, Kansas City, MO, USAPSU15 Bristol-Myers Squibb, Rueil-Malmaison, FrancePSU16 Instituto de Salud Carlos III, Madrid, SpainPSU17 None




PSU18 National Health Service, Madrid, SpainPSU19 NonePSU20 AATM, Barcelona, Spain; FIS, Madrid, SpainPSU21 NonePSU22 Alcon Laboratories, Fort Worth, TX, USAPSU23 NonePSU24 NonePSU25 Instituto de Salud Carlos III, Madrid, SpainPSU26 NonePSU27 NonePSU28 NonePSY1 Janssen Global Services LLC, Beerse, BelgiumPSY2 Abbott Canada, St-Laurent, QC, CanadaPSY3 Johnson&Johnson Medical, Madrid, SpainPSY4 Merck & Co, Whitehouse Station, NJ, USAPSY5 Gruenenthal GmbH, Aachen, GermanyPSY6 Amgen, Thousand Oaks, CA, USAPSY7 NonePSY8 Astellas Pharma, Madrid, SpainPSY9 NonePSY10 Ipsen Pharma, Barcelona, SpainPSY11 NonePSY12 Eli Lilly and Company, Indianapolis, IN, USAPSY13 Eli Lilly and Company, Indianapolis, IN, USAPSY14 Eli Lilly and Company, Indianapolis, IN, USAPSY15 NonePSY16 Novo Nordisk A/S, Soborg, DenmarkPSY17 GlaxoSmithKline, Stockley Park, UKPSY18 Pfizer Pharmaceutics Inc., Sao Paulo, BrazilPSY19 Amgen Europe, Zug, SwitzerlandPSY20 Glaxo Smith Kline, Paris, FrancePSY21 Eli Lilly and Company, Indianapolis, IN, USAPSY23 Pfizer, Madrid, SpainPSY24 Pfizer, Madrid, SpainPSY25 NonePSY26 NonePSY27 Amgen (Europe) GmbH, Zug, SwitzerlandPSY28 Baxter Healthcare, Harlow, UKPSY29 Astellas, Vienna, AustriaPSY30 NonePSY31 Grunenthal GmbH, Aachen, GermanyPSY32 Grunenthal GmbH, Aachen, GermanyPSY33 GlaxoSmithKline, Moscow, RussiaPSY34 Vifor Ltd., Zurich, SwitzerlandPSY35 Genesis Pharma SA, Athens, GreecePSY36 National Institute for Health Research, Southampton, UKPSY37 Ethicon, Paris, FrancePSY38 GlaxoSmithKline, Research Triangle Park, NC, USAPSY39 None

PSY40 Grunenthal GmbH, Aachen, GermanyPSY41 Canadian Haemophilia Society, Toronto, ON, CanadaPSY42 Pfizer Deutschland DmbH, Berlin, AL, GermanyPSY43 Novo Nordisk A/S, Søborg, DenmarkPSY44 Eli Lilly and Company, Indianapolis, IN, USAPSY45 UCB, Brussels, BelgiumPSY46 ZonMw, Den Haag, The NetherlandsPSY47 Baxter, Deerfield, IL, USAPSY48 NonePSY49 PFSA, Castres, FrancePSY50 PFSA, Castres, FrancePSY51 NonePSY52 NonePSY53 Medco Health Solutions, Inc, Franklin Lakes, NJ, USAPSY54 NonePSY55 Dutch Society for Hematology, Amsterdam, The NetherlandsPSY56 NonePSY57 CSD Medical Research, London, UKPSY58 Pfizer, Madrid, SpainPUK1 Astellas Pharma Europe Ltd., Staines, UKPUK2 Takeda Global Research & Development Centre (Europe) Ltd., London, UKPUK3 NonePUK4 Bristol Myer Squibb, Princeton, NJ, USAPUK5 Bristol-Myers Squibb EU, Paris, FrancePUK6 PFSA, Boulogne, FrancePUK7 NonePUK8 Mitsubishi Tanabe Pharma America (MTPA), Inc., Warren, NJ, USAPUK9 NonePUK10 Astellas Pharma Europe Ltd., Staines, UKPUK11 Gambro Hospal GmbH, Gröbenzell, GermanyPUK12 Eli Lilly and Company, Indianapolis, IN, USAPUK13 NonePUK14 NonePUK15 Amgen Europe, Zug, SwitzerlandPUK16 Pfizer, Madrid, SpainRS1 Association of British Pharmaceutical Industry, London, UKRS2 Costello Medical Consulting Ltd., Cambridge, UKRS3 Bristol-Myers Squibb, Braine L’Alleud, BelgiumRS4 Costello Medical Consulting, Cambridge, UKUT1 NoneUT2 NoneUT3 Medical Research Council, London, UKUT4 Grunenthal GmbH, Aachen, GermanyVI1 ZonMw, DenHaag, The NetherlandsVI2 NoneVI3 Roche Oy, Espoo, FinlandVI4 None




Download - ISPOR 14th annual European congress financial disclosure information for research presetnations

Top Related